Cases

Search for a case

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Cases

April 4, 2024

Doma Holdings Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Doma Holdings Inc. (“Doma” or the “Company”) (NYSE: DOMA), in connection with its acquisition by Title Resources Group. Under the merger agreement, the Company’s shareholders will receive $6.29 per share.

Join Case →

April 4, 2024

Fusion Pharmaceuticals Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Fusion Pharmaceuticals Inc. (“Fusion” or the “Company”) (NASDAQ: FUSN) in connection with its proposed acquisition by a subsidiary of AstraZeneca. Under the merger agreement, the Company’s shareholders will receive $21.00 per share at closing plus a non-transferable contingent value right (“CVR”) of $3.00 per share payable upon the achievement of a specified regulatory milestone.

Join Case →

April 4, 2024

Landos Biopharma, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Landos Biopharma, Inc. (“Landos” or the “Company”) (NASDAQ: LABP), in connection with its acquisition by AbbVie Inc. (NYSE: ABBV). Under the merger agreement, the Company’s shareholders will receive $20.42 per share plus one non-tradable contingent value right (“CVR”) per share with avalue of up to $11.14 per share, subject to the achievement of a clinical development milestone.

Join Case →

April 4, 2024

AdTheorent Holding Company, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of AdTheorent Holding Company, Inc. (“AdTheorent” or the “Company”) (NASDAQ: ADTH), in connection with its acquisition by Cadent. Under the merger agreement, the Company’s shareholders will receive $3.21 per share.

Join Case →

March 11, 2024

The Chemours Company Investigation

We are investigating possible breaches of fiduciary duty and violations of the federal securities laws by, among others, the Board of Directors and senior officers of The Chemours Company (NYSE: CC) (“Chemours” or the “Company”) concerning the Company’s suspension of its chief and senior executives pending an internal review over suspicious accounting and compensation practices.

Join Case →

March 11, 2024

Everi Holdings Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Everi Holdings Inc. (“Everi” or the “Company”) (NYSE: EVRI) in connection with its acquisition by International Game Technology PLC (“IGT”) (NYSE: IGT). Upon completion of the transaction, IGT shareholders will own 54% of the combined company, while Everi shareholders will only own 46%.

Join Case →

March 11, 2024

Superior Drilling Products, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Superior Drilling Products, Inc. (“Superior Drilling” or the “Company”) (NYSE: SDPI), in connection with its acquisition by Drilling Tools International Corp. (“DTI”) (NASDAQ: DTI) . Under the merger agreement, DTI agreed to acquire Superior Drilling for total consideration of approximately $32.2 million payable in cash and DTI stock.

Join Case →

March 11, 2024

The L.S. Starrett Company Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of The L.S. Starrett Company (“Starrett” or the “Company”) (NYSE: SCX) in connection with its acquisition by an affiliate of MiddleGround Capital. Under the merger agreement, the Company’s shareholders will receive $16.19 per share.

Join Case →

February 22, 2024

VIZIO Holding Corp. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of VIZIO Holding Corp. (“VIZIO” or the “Company”) (NYSE: VZIO) in connection with its acquisition by Walmart Inc. (NYSE: WMT). Under the merger agreement, the Company’s shareholders will receive $11.50 per share. The transaction is valued at approximately $2.3 billion.

Join Case →

We will fight for you and have your back no matter what. Join the tens of thousands of people we’ve helped.

Cases

Search for a case

Cases

Doma Holdings Inc. Investigation

Fusion Pharmaceuticals Inc. Investigation

Landos Biopharma, Inc. Investigation

AdTheorent Holding Company, Inc. Investigation

The Chemours Company Investigation

Everi Holdings Inc. Investigation

Superior Drilling Products, Inc. Investigation

The L.S. Starrett Company Investigation

VIZIO Holding Corp. Investigation

Where to find us?

new york

california

georgia

NEW JERSEY